Fasimec Duo 50 mg/ml + 1 mg/ml oral suspension for sheep

Šalis: Airija

kalba: anglų

Šaltinis: HPRA (Health Products Regulatory Authority)

Nusipirk tai dabar

Prekės savybės Prekės savybės (SPC)
12-06-2017

Veiklioji medžiaga:

Triclabendazole, Ivermectin

Prieinama:

Elanco Europe Ltd

ATC kodas:

QP54AA51

INN (Tarptautinis Pavadinimas):

Triclabendazole, Ivermectin

Dozė:

50/1 milligram(s)/millilitre

Vaisto forma:

Oral suspension

Recepto tipas:

LM: Licensed Merchant as defined in relevant national legislation

Farmakoterapinė grupė:

Sheep

Gydymo sritis:

ivermectin, combinations

Terapinės indikacijos:

Endoparasiticide

Autorizacija statusas:

Authorised

Leidimo data:

2016-06-17

Prekės savybės

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Fasimec Duo 50 mg/ml + 1 mg/ml oral suspension for sheep.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Oral suspension
Cream coloured aqueous oral suspension.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
For sheep over 3 months of age.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of mixed trematode (fluke) and nematode or arthropod
infections due to gastrointestinal roundworms,
lungworms, liver fluke and nasal bots.
GASTROINTESTINAL NEMATODES (ADULT AND IMMATURE):
_Haemonchus contortus, Teladorsagia (Ostertagia) circumcincta,
Trichostrongylus spp, Cooperia spp, Nematodirus spp_
including_ N. battus_,_ Strongyloides papillosus, Oesophagostomum
spp_, and adult_ Chabertia ovina._
Inhibited larval
stages and benzimidazole resistant
strains of_ Haemonchus contortus_ and_ Teladorsagia (Ostertagia)_
_circumcincta_ are also controlled.
LIVER FLUKE (MATURE, IMMATURE AND EARLY IMMATURE STAGES DOWN TO LESS
THAN 1 WEEK OF AGE):
_Fasciola hepatica_
LUNGWORMS (ADULT AND IMMATURE):
_Dictyocaulus filaria_
NASAL BOTS (ALL STAGES):
_Oestrus ovis_
4.3 CONTRAINDICATIONS
Do not use in animals with known hypersensitivity to the active
ingredients or any of the excipients.
ACTIVE INGREDIENTS:
Ivermectin
1
mg/ml
Triclabendazole
50
mg/ml
EXCIPIENTS:
Methyl parahydroxybenzoate (E218)
1.4 mg/ml
Propyl parahydroxybenzoate (E216)
0.5 mg/ml
Benzyl alcohol
5.0 mg/ml
For a full list of excipients, see section 6.1.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_
                                
                                Perskaitykite visą dokumentą
                                
                            

Ieškokite perspėjimų, susijusių su šiuo produktu